Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70346 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Kevser Kübra Kırboğa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Engineering, Department of Bioengineering, Bilecik Seyh Edebali University, Bilecik, Türkiye. Hauptthemen laut MEDLINE: Lactoperoxidase, Iridium, Amides, Enzyme Inhibitors. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Lactoperoxidase (LPO, EC 1.11.1.7), a heme metalloenzyme central to innate antimicrobial defence and implicated in mammary carcinogenesis, remains an underexplored target for metal‐based inhibitors. We evaluated six cyclometalated iridium(III) complexes bearing 2,2′‐bipyridine‐4,4′‐dicarboxamide ancillary ligands with varied N‐substituents as LPO inhibitors. Kinetic analysis using LPO purified from bovine milk revealed nanomolar inhibition (IC 50 = 0.64–3.12 nM; Kᵢ = 0.05 ± 0.01–5.36 ± 1.88 nM), representing an approximately 10 7 ‐fold potency advantage over the benchmark sulfonamide acetazolamide. Lineweaver–Burk analysis showed substituent‐dependent inhibition: complexes 1, 2, and 4 were competitive, whereas 3, 5, and 6 were non‐competitive, indicating that peripheral steric features influence the inhibition mechanism. Density functional theory calculations showed smaller HOMO–LUMO gaps and higher electrophilicity indices than acetazolamide, although no single descriptor predicted activity within the series. Molecular docking supported binding within the distal heme cavity, with representative interactions including π–π stacking and hydrogen bonding involving Gln‐105 and His‐109. All complexes reduced MDA‐MB‐231 cell viability; among those with reliably determined IC 50 values, complex 4 showed the greatest cytotoxicity (IC 50 = 18.28 µM). These findings identify amide‐linked Ir(III) complexes as highly potent LPO inhibitors with substituent‐dependent inhibition modes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Engineering, Department of Bioengineering, Bilecik Seyh Edebali University, Bilecik, Türkiye.
- Science and Advanced Technologies Research Center (BILTAM), Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Molecular Biology and Genetics, Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Chemistry, Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Engineering Basic Sciences, Istanbul Medeniyet University, Istanbul, Türkiye.
ORCID-Profile: Kevser Kübra Kırboğa, Fatma Sağır, Zeynep Köksal
Zitieren
APA
Kırboğa, K. K., Sağır, F., Köksal, Z., & Şahin, Ç. (2026). Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70346
Vancouver
Kırboğa KK, Sağır F, Köksal Z, Şahin Ç. Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70346
BibTeX
@article{Krboa2026,
author = {Kırboğa, Kevser Kübra and Sağır, Fatma and Köksal, Zeynep and Şahin, Çiğdem},
title = {Steric Control of Competitive Versus Noncompetitive Lactoperoxidase Inhibition by Amide‐Linked Iridium(III) Complexes},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70346}
}
EUVIMED